ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP51-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2025
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 11, 2025
လံာ်တီလံာ်မီတဖၣ်ဒီး လံာ်ကွီၣ်ဒိတဖၣ်အစၢတဖၣ်
တၢ်ပာ်ဖျါ 101 - 110 လၢ 3159 အစၢတဖၣ်အကျါ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP50-25 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2025
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 11, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP49-25 MHCP Pharmacy Benefit Exclusion for Imaavy™, Lutrate Depot®, Tepylute, Ustekinumab and Ustekinumab-aekn
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 11, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 11, 2025
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
QP47-25 Updated Accessibility Requirements
တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 11, 2025
ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Medicaid Reimbursement Policy Cellular and Gene Therapy Products
ကျိၣ်စ့တၢ်ဂ့ၢ်တၢ်ကျိၤ
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်
Commercial Reimbursement Policy Cellular and Gene Therapy Products
This policy addresses coding and reimbursement for Cellular and Gene Therapy Products. This policy does not apply to FEP.
တၢ်ဃ့က့ၤအဘူးအလဲ ဒီးတၢ်ပတံသကွံာ်ကညးတၢ်တဖၣ်
Blue Cross and Blue Shield of Minnesota Self-Insured Complaint Form
တၢ်ဃ့က့ၤအဘူးအလဲ ဒီးတၢ်ပတံသကွံာ်ကညးတၢ်တဖၣ်
BCBS Fully Insured Complaint Form